BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of ...

BD (NYSE:BDX) announced today that it launched its Pyxis Pro Dispensing Solution and Incada Connected Care Platform in Europe ...

BDX rolls out AI-powered Pyxis Pro and Incada platforms in Europe, aiming to boost hospital efficiency, improve medication ...

Stephens has initiated coverage on Pyxis Oncology Inc (NASDAQ:PYXS), highlighting the company’s technology platform aimed at developing next-gen antibody-drug conjugates (ADCs) with enhanced potency, ...

When patients begin receiving care at St. Luke's Same Day Surgery Center in April, they'll receive medications through a computerized pharmacy system that's been in use throughout St. Luke's Regional ...

On Wednesday, Pyxis Oncology, Inc. (NASDAQ:PYXS) released preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in multiple solid tumors. Among evaluable Head and ...

BD said it would issue software updates for two of its products after discovering separate privacy concerns and potential hacking risks in each. The affected technologies are BD’s Pyxis systems for ...

Investing.com - Jefferies raised its price target on Pyxis Oncology Inc. (NASDAQ:PYXS) to $8.00 from $7.40 while maintaining a Buy rating on the stock. The new target represents significant upside ...